Thank-you for confirming my posts regarding the reason for the termination of the agreement.
The statement is clear and speaks for itself.
The question now remains, why couldn't SI have simply given that information to investors?
Surely having that as a reference would be helpful in assessing the company and it's risks and their narrative.
IMO it is ominous when considering the independent expert opinions on their trials and scrutiny of their data by the FDA.
MSB Trading 2021 - paradigm shift, page-9736
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |